Switching from Insulin Degludec plus Dipeptidyl Peptidase-4 Inhibitor to Insulin Degludec/Liraglutide Improves Glycemic Variability in Patients with Type 2 Diabetes: A Preliminary Prospective Observation Study.
J Diabetes Res. 2022 Jan 19;2022:5603864. doi: 10.1155/2022/5603864. eCollection 2022.
J Diabetes Res. 2022.
PMID: 35097130
Free PMC article.